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Background/aim: Although routine ophthalmoscopy is recommended in the evaluation of people with
hypertension, the prognostic significance of retinopathy is unknown. The purpose of this study is to
determine if hypertensive retinopathy predicts coronary heart disease (CHD).
Methods: A prospective cohort study involving 560 hypertensive, hyperlipidaemic, middle aged men
enrolled in the Lipid Research Clinic’s Coronary Primary Prevention Trial. Signs of hypertensive retino-
pathy (generalised and focal arteriolar narrowing, arteriovenous nicking, widened arteriolar light
reflex, retinal haemorrhage and exudates, microaneurysms, and disc swelling) were evaluated by
direct funduscopy during a baseline examination by study physicians. Incident CHD events were ascer-
tained from hospital records, necropsy reports, and death certificates, and reviewed by a masked
panel of cardiologists.
Results: There were 51 definite CHD events (definite CHD deaths or myocardial infarctions) during a
median follow up of 7.8 years. After adjusting for age, blood pressure, electrocardiographic manifes-
tations of left ventricular hypertrophy, cholesterol levels and treatment, glucose and creatinine levels,
and smoking status in proportional hazards analysis, the presence of hypertensive retinopathy
predicted a doubling of the risk of definite CHD events (relative risk 2.1; 95% confidence interval (CI)
1.0 to 4.2 ). The presence of either generalised or focal arteriolar narrowing predicted almost a tripling
of the risk (relative risk 2.9; 95% CI 1.3 to 6.2). Associations were similar for stage 1 hypertension
(systolic and diastolic blood pressures of 140–159 and 90–99 mm Hg, respectively) and for other
CHD end points.
Conclusion: Hypertensive retinopathy predicts CHD in high risk men, independent of blood pressure
and CHD risk factors. The data support the concept that retinal microvascular changes are markers of
blood pressure damage and may be useful in risk stratification and in the tailoring of hypertension
treatment decisions.
The Joint National Committee on the Prevention, Detec-tion, Evaluation, and Treatment of High Blood Pressure inthe United States and the British Society of Hypertension
recommend routine ophthalmoscopic examination to detect
signs of retinopathy in people with hypertension for the pur-
poses of risk stratification and treatment decisions.1 2 However,
little is known about the prognostic significance of retino-
pathy in hypertensive individuals.3 A number of studies have
indicated that hypertensive individuals with retinopathy have
higher mortality rates, and possibly higher morbidity rates
from cardiovascular diseases.4–10 However, these studies have
important limitations. Firstly, the majority were conducted
before 1970, and it is uncertain if the data still apply to
contemporary populations. For example, the more severe reti-
nal changes described in these studies (for example, soft
exudates/cotton wool spots and optic disc swelling) have been
shown to be relatively uncommon in populations with better
blood pressure control.11 Secondly, although retinopathy was
shown to be predictive of overall mortality in these studies,
specific cardiovascular outcomes (such as incident CHD, or
CHD mortality) have not been evaluated. Further, the effect of
potential confounders of any retinopathy-cardiovascular
disease association (such as blood pressure level, clinically
detected left ventricular hypertrophy or renal damage, smok-
ing and lipid levels) is not known. Thus, clinical data on
whether retinopathy provides useful predictive information
for the purpose of CHD risk stratification beyond that already
obtained by measuring blood pressure and lipid levels are not
currently available. Partly because of these limitations, the
value of retinal evaluation in people with hypertension has
been questioned.12–15
The purpose of this study was to investigate whether hyper-
tensive retinopathy, as diagnosed by physicians using direct
ophthalmoscopy, predicts the long term incidence of CHD,
independent of blood pressure and other cardiovascular risk
factors. Hypertensive men participating in the Lipid Research
Clinics Coronary Primary Prevention Trial (LRC-CPPT) pro-
vided the basis for this investigation.
METHODS
Study population
The LRC-CPPT cohort and procedures have been described
elsewhere.16–19 Briefly, between 1973 and 1976, a total of 3806
men aged 35–59 years with type II-a hyperlipidaemia (total
cholesterol > 6.85 mmo/l or 265 mg/dl, low density lipoprotein
cholesterol (LDL-cholesterol) > 4.91 mmol/l or 190 mg/dl, and
triglycerides <3.39 mmol/l or 300 mg/dl), and without
clinically apparent CHD were randomised into two treatment
groups, one receiving cholestyramine resin and the other an
inert placebo. Though recruitment involved both clinical and
community based approaches, most participants were re-
cruited through community based strategies. Additional
exclusion criteria included blood pressure =180/120 mm Hg at
one of the four prerandomisation visits, or =160/105 mm Hg
at more than one of the last three of these prerandomisation
visits; the use of antihypertensive medication, a history of
stroke or transient ischaemic attack; significant peripheral
vascular disease (previous surgery or symptoms limiting
treadmill examination); aortic aneurysm; diabetes mellitus
(fasting glucose > 130 mg/dl or receiving insulin or oral
hypoglycaemics); thyroid disease; nephrotic syndrome; the
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presence of a debilitating disease; serum creatinine =176.8
µmol/l or 2 mg/dl or a urine protein concentration of 2+; and
left ventricular hypertrophy, as defined electrocardiographi-
cally by an Estes score of 5.20
This analysis is confined to the 588 individuals character-
ised as having hypertension on the basis of a mean systolic
and diastolic blood pressure at visits 1 and 2 of 140 or 90 mm
Hg, respectively. Of these, 28 (4.8%) were excluded owing to
either a missing ophthalmoscopic examination or ungrade-
able retina, leaving 560 for further analyses.
Procedures
The procedures and criteria for CHD case definitions have
been published elsewhere.16 18 The median in-trial period was
7.8 years with bimonthly follow up and yearly physical exami-
nations (up to 1983). Medical records, electrocardiograms,
death certificates, and necropsy records were reviewed for all
participants. CHD was ascertained by a blinded panel of cardi-
ologists according to a standardised protocol described
previously.16 18
After reviewing the patient’s blood pressure and obtaining a
history oriented towards cardiovascular disease, study physi-
cians performed direct ophthalmoscopy without mydriasis at
the beginning of a general physical examination. The follow-
ing individual lesions were documented as present versus
absent: generalised and focal arteriolar narrowing, arterio-
venous nicking, widened arteriolar light reflex, retinal haem-
orrhage and exudates, microaneurysms and disc swelling.
Hypertensive retinopathy was defined to include the presence
of any one of the above lesions.
Definitions and statistical analysis
The primary end point in this analysis is a definite CHD event,
defined as either a definite CHD death or a definite myocardial
infarction. Additionally, the LRC classified suspected CHD
events and any coronary event.16 18 Individual retinal lesions
were analysed separately, and an aggregate variable, any
retinopathy, was defined as the presence of any of the above
mentioned specific retinal lesions. A separate aggregate retin-
opathy variable was created excluding a widened light reflex,
because this was felt to be the most subjective of all the reti-
nal signs. Cox proportional hazards regression models21 were
constructed to estimate the relative risk (RR) of CHD, in the
presence or absence of retinopathy, adjusting for (1) age, (2)
age and hypertension indicators (systolic blood pressure,
diastolic blood pressure, creatinine levels, and left ventricular
hypertrophy score, based on electrocardiographic findings21),
and (3) age, hypertension indicators, and other CHD risk fac-
tors used in risk stratification of hypertensive individuals
(total cholesterol, LDL-cholesterol, high density lipoprotein
(HDL)-cholesterol, current or exsmoking status, and fasting
glucose levels at baseline) as well as cholesterol treatment sta-
tus. These were selected for inclusion in the models as they are
risk factors that might be already considered in the manage-
ment decision to treat a hypertensive patient, based on current
recommendations.1 Proportional hazards assumption was
visually verified by plotting log of cumulative hazard function
comparing presence or absence of any retinopathy over the 7.8
years of follow up. Next, analyses were repeated in men with
stage 1 hypertension (defined as systolic blood pressure of
140–159 and diastolic blood pressure of 90–99 mm Hg1) and
for other CHD end points (definite CHD deaths, definite myo-
cardial infarction, suspected and definite CHD, and any coron-
ary event). Finally, the principal retinal variables were entered
simultaneously in a model to evaluate whether the predictive
ability of each retinal lesion was independent of that of the
others.
RESULTS
Of the 560 men included in this study, 498 (88.9%) had stage
1 hypertension (140–159/90–99 mm Hg) and 62 (11.1%) stage
2 (160–169/100–109 mm Hg) disease. At baseline, 65 (11.6%)
participants had signs of retinopathy. Of the specific lesions
detected, 32 (5.7%) had generalised arteriolar narrowing,
eight (1.4%) focal arteriolar narrowing, 18 (3.2%) arterio-
venous nicking, and 20 (3.6%) a widened arteriolar light
reflex. One individual was found to have microaneurysms,
without retinal haemorrhages, retinal exudates, or disc swell-
ing. With respect to other CHD risk factors, 261 (47%) were
current and 154 (28%) were ex-smokers; and 18 (3.2%) had
an Estes score of 4, suggesting possible left ventricular hyper-
trophy.
During the 7.8 median years of follow up, 51 men (9.1%)
had a definite CHD event. Of these, 43 (7.7%) had a definite
myocardial infarction and 13 (2.3%) a definite CHD death
(events not mutually exclusive, five men had both a definite
myocardial infarction followed by a definite CHD death). In
addition, 18 men (3.2%) had a suspected CHD event.
Summing these with other coronary end points, a total of 171
men (30.5%) had a coronary event. In general, baseline char-
acteristics were similar in participants with (n = 51) versus
without (n=509) definite CHD events (Table 1), except that
men with definite CHD events were older, and had lower
baseline HDL-cholesterol levels).
The age adjusted RRs of CHD for retinal findings are shown
in Table 2. The presence of any retinopathy predicted a twofold
higher risk for definite CHD (RR 2.1; 95% CI 1.1 to 4.1), for its
subcategory definite myocardial infarction (RR 2.0; 95% CI 1.0
Table 1 Baseline characteristics comparing men with definite CHD (n=51) versus
those without definite CHD (n=509), participating in the Lipid Research Clinics
Coronary Primary Prevention Trial
Characteristic at baseline
Definite CHD No definite CHD
p Value†Mean (SE)* Mean (SE)*
Age (years) 51.3 (0.9) 48.9 (0.3) 0.01
Systolic blood pressure (mm Hg) 139.3 (1.3) 137.7 (0.4) 0.24
Diastolic blood pressure (mm Hg) 92.2 (0.8) 92.7 (0.3) 0.60
Total cholesterol (mg/dl) 292.9 (4.6) 295.1 (1.4) 0.65
LDL-cholesterol (mg/dl) 214.8 (4.4) 215.7 (1.4) 0.85
HDL-cholesterol (mg/dl) 42.1 (1.6) 46.0 (0.5) 0.02
Creatinine (mg/dl) 1.03 (0.02) 1.03 (0.01) 0.83
Fasting glucose (mg/dl) 98.9 (1.4) 100.5 (0.4) 0.26
Average cigarettes smoked‡ 29.3 (2.9) 24.2 (1.2) 0.10
*SE = standard error.
†p Values are based on age adjusted comparison of mean values between men with versus without definite
CHD (except for age).
‡Excluding never smokers.
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to 4.2) and also for definite CHD among men with stage 1
hypertension only (RR 2.2; 95% CI 1.0 to 4.5). These findings
did not vary significantly after excluding those with only a
widened light reflex. The presence of arteriolar narrowing
(either generalised or focal) predicted a nearly threefold
higher risk of CHD. For specific retinal lesions and definite
CHD, the RR ranged from 1.7 (95% CI 0.5 to 5.4) for widened
light reflex to 2.9 (95% CI 0.7 to 12.1) for focal arteriolar nar-
rowing, although only the association for generalised arteri-
olar narrowing was statistically significant (RR 2.6; 95% CI,
1.2 to 5.8). When the data were analysed including suspected
CHD events, the results were similar (Table 2). When any cor-
onary event was the outcome of interest, the associations were
weaker.
After adjusting for systolic and diastolic blood pressure, cre-
atinine levels, and electrocardiographic manifestations of left
ventricular hypertrophy, men with any retinopathy had 2.2
(95% CI, 1.1 to 4.3) times the risk of CHD than those without
(Table 3). This association was not attenuated after further
adjusting for other cardiovascular risk factors (RR of 2.1, 95%
CI, 1.0 to 4.2) and was similar to that found for the
subcategory definite myocardial infarction alone. Likewise,
the associations did not change after excluding those with
only a widened light reflex, and were stronger for arteriolar
narrowing (multivariate RRs of 2.9 for any narrowing and 2.5
for generalised narrowing, respectively). When the analysis
was confined to men with stage 1 hypertension, the
associations were of similar strength.
Table 2 Age adjusted relative risk (RR) of coronary heart disease (CHD) death or myocardial infarction (MI), by the
presence of retinal abnormalities, among hypertensive participants of the LRC-CPPT





eventDeath or MI MI only
Death or MI in
men with stage
1 hypertension*
Any retinopathy 65 11.6 2.1 (1.1 to 4.1) 2.0 (1.0 to 4.2) 2.2 (1.0 to 4.5) 1.8 (1.0 to 3.2) 1.3 (0.8 to 2.0)
Any retinopathy, except widened light reflex 51 9.1 2.1 (1.0 to 4.3) 1.9 (0.8 to 4.2) 2.2 (1.0 to 4.8) 1.8 (1.0 to 3.5) 1.3 (0.8 to 2.0)
Arteriolar narrowing
Generalised or focal 38 6.8 3.1 (1.5 to 6.3) 2.7 (1.2 to 6.2) 3.1 (1.4 to 7.1) 2.7 (1.4 to 5.2) 1.6 (1.0 to 2.6)
Generalised 32 5.7 2.6 (1.2 to 5.8) 2.1 (0.8 to 5.4) 2.5 (1.0 to 6.3) 2.5 (1.2 to 5.0) 1.6 (1.0 to 2.8)
Focal 8 1.4 2.9 (0.7 to 12.1) 3.4 (0.8 to 14.2) 4.0 (1.0 to 16.8) 2.1 (0.5 to 8.5) 0.7 (0.2 to 3.0)
Arteriovenous nicking 18 3.2 1.8 (0.6 to 5.7) 1.4 (0.3 to 5.6) 2.9 (0.9 to 9.2) 1.7 (0.6 to 4.8) 1.0 (0.4 to 2.2)
Widened light reflex 20 3.6 1.7 (0.5 to 5.4) 2.0 (0.6 to 6.4) 1.7 (0.5 to 5.6) 1.2 (0.4 to 3.8) 1.1 (0.5 to 2.4)
Figures are age adjusted RRs. Figures in parentheses denote 95% confidence intervals.
*Defined by systolic and diastolic blood pressure levels of 140–159 and 90–99 mm Hg, respectively.
Table 3 Multivariate relative risk (RR) of definite coronary heart disease (CHD) death or myocardial infarction (MI), by
the presence of retinal abnormalities, adjusted for hypertension† and other CHD risk factors‡, among hypertensive
participants of the LRC-CPPT
Retinal abnormalities
Death or MI MI only














Any retinopathy 2.2 (1.1 to 4.3) 2.1 (1.0 to 4.2) 2.0 (0.9 to 4.2) 1.9 (0.9 to 4.2) 2.1 (1.0 to 4.5) 2.0 (0.9 to 4.5)
Any retinopathy except for widened light
reflex 2.2 (1.0 to 4.6) 2.0 (1.0 to 4.3) 1.9 (0.8 to 4.3) 1.7 (0.7 to 4.1) 2.2 (1.0 to 5.0) 1.9 (0.8 to 4.5)
Arteriolar narrowing
Generalised or focal 3.3 (1.5 to 6.9) 2.9 (1.3 to 6.2) 2.8 (1.2 to 6.4) 2.4 (1.0 to 5.8) 3.1 (1.3 to 7.1) 2.6 (1.1 to 6.3)
Generalised only 2.8 (1.2 to 6.5) 2.5 (1.1 to 5.9) 2.2 (0.8 to 5.8) 1.9 (0.7 to 5.2) 2.5 (0.9 to 6.5) 2.3 (0.8 to 6.1)
Arteriovenous nicking 1.9 (0.6 to 6.2) 2.1 (0.6 to 6.9) 1.5 (0.4 to 6.3) 1.6 (0.4 to 6.9) 3.3 (1.0 to 10.9) 3.2 (1.0 to 10.7)
Widened light reflex 1.6 (0.5 to 5.3) 1.8 (0.5 to 6.1) 1.8 (0.6 to 6.0) 2.2 (0.6 to 7.6) 1.6 (0.5 to 5.2) 1.8 (0.5 to 6.1)
*Defined by systolic and diastolic blood pressure levels of 140–159 and 90–99 mm Hg, respectively.
†Adjusted for age, systolic and diastolic blood pressure, creatinine levels, and left ventricular hypertrophy score at baseline.
‡Adjusted for above factors plus total cholesterol, LDL-cholesterol, HDL-cholesterol, cholesterol treatment status, current or ex-smoking status, and fasting
glucose levels at baseline. Figures in parentheses denote 95% confidence intervals.
Table 4 Multivariate relative risk (RR) of definite coronary heart disease (CHD) death or myocardial infarction (MI) by
individual retinal abnormalities when adjusted simultaneously for other retinal abnormalities, for hypertension† and other
CHD risk factors‡, among hypertensive participants of the LRC-CPPT
Retinal abnormalities
Death or MI MI only














Generalised or focal arteriolar narrowing 3.1 (1.4 to 6.8) 2.7 (1.2 to 5.9) 2.6 (1.1 to 6.3) 2.2 (0.9 to 5.5) 2.9 (1.2 to 7.0) 2.5 (1.0 to 6.2)
Arteriovenous nicking 1.6 (0.5 to 5.3) 1.7 (0.5 to 5.8) 1.3 (0.4 to 4.5) 1.3 (0.3 to 5.8) 3.0 (0.9 to 10.5) 2.9 (0.8 to 10.2)
Widened light reflex 1.1 (0.3 to 3.7) 1.3 (0.4 to 4.7) 1.2 (0.3 to 5.3) 1.8 (0.5 to 6.5) 0.9 (0.3 to 3.3) 1.1 (0.3 to 4.4)
*Defined by systolic and diastolic blood pressure levels of 140–159 and 90–99 mm Hg, respectively.
†Adjusted for age, systolic and diastolic blood pressure, creatinine levels, and left ventricular hypertrophy score at baseline.
‡Adjusted for above factors plus total cholesterol, LDL-cholesterol, HDL-cholesterol, cholesterol treatment status, current or ex-smoking status, and fasting
glucose levels at baseline. Figures in parentheses denote 95% confidence intervals.
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Additional analyses were performed for other CHD end
points, with similarly consistent results. For example, arteri-
olar narrowing predicted a higher risk of definite CHD deaths
(age adjusted RR of 4.2; 95% CI, 1.2 to 15.5) and any coronary
events (multivariate RR 1.7; 95% CI 1.0 to 2.8). On the other
hand, for non-CHD deaths (n=13), no associations were
found. Finally, in models with all retinal variables entered
simultaneously (Table 4), generalised or focal arteriolar
narrowing independently predicted a higher rate of definite
CHD, other abnormalities predicting small, but not statisti-
cally significant, additional risk.
DISCUSSION
Hypertensive retinopathy consists of a spectrum of retinal
vascular changes that are pathologically related to both tran-
sient and persistent microvascular damage from elevated
blood pressure.22 23 The relation between blood pressure and
the presence and severity of theses changes are well
established, and confirmed in several large population based
studies.10 11 24–27 The important issue of the prognostic signifi-
cance of this retinopathy, however, has remained unclear. Does
it merely reflect blood pressure levels (thus, providing no
additional information for the management of hypertension
over that obtained by measuring blood pressure); or does it
offer important predictive information about cardiovascular
health, beyond blood pressure measurement?
In this cohort of hypertensive, hyperlipidaemic, middle
aged US men, the presence of retinopathy, as detected through
a standard direct ophthalmoscopic examination performed by
non-ophthalmologists, was associated with a twofold higher
risk of CHD death or myocardial infarction, independent of
systolic and diastolic blood pressure, left ventricular hypertro-
phy, creatinine levels, cholesterol levels and treatment, glucose
levels, and smoking status. In fact, arteriolar narrowing,
whether generalised or focal, was independently associated
with a nearly three times higher risk of CHD. The higher risk
persisted with diverse CHD end points, including definite CHD
deaths, definite myocardial infarction, suspected and definite
CHD, and any coronary event. Perhaps more importantly, the
higher risk was also seen when analyses were restricted to
those with only stage 1 hypertension, suggesting that retinal
lesions are useful predictors even in people without severe
hypertension. Although individual lesions had different
strengths of association—strongest for arteriolar narrowing,
weaker (and statistically non-significant) for arteriovenous
nicking and a widened light reflex—the overall pattern and
direction of all associations were consistent. Therefore, these
data suggest that this retinopathy is an independent prognos-
tic indicator of CHD risk in people with hypertension, and
support the use of ophthalmoscopic examination for risk
stratification, even for Stage 1 hypertension.
The current literature provides limited and inconsistent
data on the association between retinopathy and either
cardiovascular disease or cardiovascular mortality.3 Some
studies have indicated that retinal changes may be associated
with CHD even in people without hypertension. In a cross sec-
tional study of 70 non-diabetic and non-hypertensive subjects
undergoing coronary angiography, retinal lesions were associ-
ated with both the presence and severity of coronary artery
disease.28 In another cross sectional study based on data from
the National Health Examination Survey, retinal changes were
associated with a fourfold higher prevalence of CHD in white
men aged 35–54 years and a sixfold higher prevalence in white
women of similar age, after controlling for hypertension,
diabetes, and cholesterol levels.29 Most recently, the Athero-
sclerosis Risk In Communities (ARIC) Study showed that
retinal arteriolar narrowing was predictive of incident CHD,
with stronger associations seen in women compared to men.30
It is not clear why the results of the ARIC study are different
from the current study, although direct comparison of the two
studies may be inappropriate, as the ARIC study was
conducted among low risk men and women, and used retinal
photographs for the assessment of retinal microvascular
abnormalities.
In hypertensive people, the biological rationale for an
association between hypertensive retinopathy and CHD is
even stronger, as retinopathy results from arteriolar damage
from elevated blood pressure, and it is reasonable to expect
that microvascular damage in the retinal arterioles may be
associated with concurrent microvascular damage in the cor-
onary circulation as well. This was recognised as early as 1939
by Keith et al, when they showed a dose dependent increase in
mortality with increasingly severe retinal changes.4 Although
numerous studies have since documented possible associa-
tions between retinopathy and CHD in hypertensive individu-
als, these studies have significant limitations.4–10 These include
possible inapplicability to current populations (for example,
only one case in our cohort met the stage 3 hypertensive
retinopathy definition proposed by Keith et al), inadequate
evaluation of specific cardiovascular outcomes and lack of
control for possible confounders. The current LRC study show
that hypertensive/arteriosclerotic retinopathy is a predictor of
CHD in high risk hypertensive men, independent of the
increased risk associated with blood pressure level and other
CHD risk factors.
A number of important limitations of this study should be
mentioned. Firstly, it should be re-emphasised that the popu-
lation was non-randomly selected, having been derived from a
multicentre clinical trial, and consisted of hyperlipidaemic,
middle age white men. Thus, caution should be taken when
extending these findings to other segments of the
population—those without hyperlipidaemia, older and
younger age groups, women, other ethnic groups, etc.
However, the fact that the association was minimally
confounded by the presence of other risk factors (lipid levels,
smoking, etc) and that cross sectional associations in the
NHANES study29 were present in a representative sample of
US males and, if anything, greater in a representative sample
of US women, supports generalisation beyond those who par-
ticipated in the trial. Secondly, medical advances in the recog-
nition and treatment of hyperlipidaemia and hypertension, by
altering the clinical course of these conditions, may have
altered somewhat the predictive ability of retinal findings to
current clinical practice. Thirdly, retinal assessment was
performed using direct ophthalmoscopy on undilated eyes by
non-ophthalmologists. Non-standardised direct ophthalmo-
scopic examination by physicians has been suggested to be
less reliable,12–15 and to compare unfavourably with standard-
ised photographic retinopathy grading systems, such as those
used in the Beaver Dam Eye Study11 and the Atherosclerosis
Risk in Communities Study.27 30 31 Finally, even though subjects
with prevalent cardiovascular disease, repeated blood pressure
measurement 160/105 mm Hg, or using antihypertension
medication were excluded from the study, study physicians
did review blood pressure and perform a medical history ori-
ented toward cardiovascular disease immediately before the
retinal examination. This knowledge could have influenced
their determination of retinal findings. However, that our
findings remained significant after adjustment for blood pres-
sure level and the presence of other cardiovascular risk factors
makes a resultant measurement bias less likely.
Significant strengths of this study should also be empha-
sised. Firstly, while standardised photographic grading in epi-
demiological research studies are inherently more valid and
precise, they are currently not widely used for risk stratifica-
tion in hypertensive individuals.3 In this regard, the lack of
standardisation and quality control of the retinal examination
should make our results clinically more relevant to standard
medical practice. Secondly, cardiovascular outcomes in the
LRC-CPPT study were rigorously validated and documented
throughout the trial and follow up.16 18 Blood pressure and
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other covariates were also measured in standardised, quality
controlled settings. Thirdly, as retinopathy is highly correlated
with blood pressure, we adjusted all models not only for blood
pressure, but creatinine levels and left ventricular hypertro-
phy, indicators of sustained elevated blood pressure. Thus, any
residual confounding from hypertension is unlikely to be sig-
nificant.
In conclusion, in hypertensive, hyperlipidaemic men, the
presence of hypertensive retinopathy was associated with a
twofold higher risk of CHD developing over a median of 7.8
years, independent of blood pressure levels and other coronary
risk factors. Further studies of retinal microvascular abnor-
malities, perhaps with more objective methods such as retinal
photography,30 31 and in populations that are more representa-
tive of patients seen in current clinical practice, are indicated
to define their prognostic significance more precisely.
Nevertheless, these results are consistent with recent data that
hypertensive retinal microvascular changes predict stroke,32
and support the current recommendation in the use of direct
retinal examination for cardiovascular risk stratification.
. . . . . . . . . . . . . . . . . . . . .
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